



Markets
/
Stocks
/
nasdaq-regn
/

Regeneron Pharmaceuticals Inc

REGN

View Detailed Chart

598.760USD

+29.850+5.25%

Close 04/30, 16:00（ET）Quotes delayed by 15 min

1.08BMarket Cap

0.24P/E TTM



Regeneron Pharmaceuticals Inc

598.760

+29.850+5.25%

Company

Intraday

30m

Today

+5.25%

5 Days

+1.86%

1 Month

-5.59%

6 Months

-28.57%

Year to Date

-15.94%

1 Year

-32.77%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 28 analysts

BUY

Current Rating

819.838

Target Price

44.11%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

561

Total

Median

Average

Company name

Ratings

Analysts

Regeneron Pharmaceuticals Inc

REGN

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Moderna Inc

MRNA

Ionis Pharmaceuticals Inc

IONS

...

112

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(6)

Neutral(4)

Buy(3)

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

13.292

Neutral

RSI(14)

41.229

Neutral

STOCH(KDJ)(9,3,3)

64.802

Sell

ATR(14)

27.081

Low Volatility

CCI(14)

-28.956

Neutral

Williams %R

51.688

Neutral

TRIX(12,20)

-0.449

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

594.004

Buy

MA10

578.735

Buy

MA20

579.599

Buy

MA50

640.643

Sell

MA100

675.861

Sell

MA200

846.887

Sell

News

More news coming soon, stay tuned...

Company

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.

Company codeREGN

CompanyRegeneron Pharmaceuticals Inc

CEODr. Leonard S. Schleifer, M.D., Ph.D

Websitehttps://www.regeneron.com/